Refractory pulmonary aspergillosis treated with caspofungin after heart-lung transplantation

Transplant International

Volumn 17, Issue 9, 2004, Pages 545-548

  Carby, Martin R ^a   Hodson, Margaret E ^a   Banner, Nicholas R ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Aspergillosis; Caspofungin; Lung transplantation

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCYTOSINE; ITRACONAZOLE; TACROLIMUS;

ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; CYSTIC FIBROSIS; DISEASE COURSE; DRUG FEVER; HEART LUNG TRANSPLANTATION; HUMAN; LUNG ASPERGILLOSIS; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUPERINFECTION; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; HEART-LUNG TRANSPLANTATION; HUMANS; MALE; PEPTIDES, CYCLIC; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RADIOGRAPHY, THORACIC; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 9944222563     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-004-0753-0     Document Type: Article

References (12)

1. McNiel K, Foweraker J, Wreghitt T. Infectious complications. In: Banner N, Polak J, Yacoub Y (eds). Lung transplantation. Cambridge University Press, 2003:250-260.
2. Ruffini E, Baldi S, Rapellino M, Cavallo A, Parola A, Robbiano F, et al. Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18:181.
3. Ascioglu S, Rex JH, de Pauw B, Bennett J, Billie J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haemopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7.
4. Subira M, Martino R, Rovira M, Vazquez L, Serrano D, De la Camara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with haematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82:80.
5. Kennedy MS, Deeg HJ, Siegel M, Crowley J, Storb R, Thornas E. Acute renal toxicity with combined use of amphotericin B and ciclosporin after marrow transplantation. Transplantation 1983; 35:211.
6. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003; 36):1445.
7. Estenne M, Maurer JR, Boehler A, Egan J, Frost A, Hertz M, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21:297.
8. Diederich S, Scadeng M, Dennis C, Stewart S, Flower C. Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings. Eur Radiol 1998; 8:306.
9. Munoz P, Alcala L, Sanchez M, Palomo J, Yanez J, Pelaez T, et al. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive in invasive aspergillosis. Transplantation 2003; 75:326.
10. Andriole V. Current and future antifungal therapy: new targets for antifungal agents. J Antimicrob Chemother 1999; 44:151.
11. Keating GM, Jarvis B. Caspofungin. Drugs 2001; 61:1121.
12. Mora-Duarte J, Betts R, Rotstein C, Colombo L, Thompson L, Smientana J, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347):2020.